GMP Inspections: Do you know IRIS?
Recommendation

23/24 June 2026
Barcelona, Spain
A Conference for GMP-Auditors to Exchange Experience
IRIS is an online platform for handling product-related scientific and regulatory procedures with the EMA. In 2018, it was established in a first step for orphan drug procedures. It was then expanded step by step. The aim is to shorten the time of applications within the framework of scientific procedures.
In the meantime, there are a number of different instructions for use and an IRIS stakeholder forum where users (primarily applicants) can find out about news (e.g. new IRIS functions, version information). It allows asking questions, submitting proposals and further discussions.
As it expands, the platform will also be used by marketing authorisation holders and applicants to communicate with the EMA about GMP inspections.
There are a lot of links to further information on the IRIS website:
- Access & submission
- Public registers & lists
- Guidance & support
- News
Related GMP News
03.06.2026GMP Auditor Association Developments January through April 2026
20.05.2026CAPA and Root Cause Analysis - why FDA keeps calling them out
20.05.2026FDA Pilots One-Day Inspectional Assessments to Expand Oversight
06.05.2026FDA Warning Letter: CAPA not only needed for Deviations
28.04.2026FDA remains active in Europe - further Inspections despite MRAs


